About this trial
Patients with congenital long QT syndrome (LQTS) have traditionally been discouraged from physical activity and competitive sports, although the rate of exercise-related arrhythmic events is considered low. In recent years, international guidelines have become less restrictive and now support shared decision-making between physicians, patients and families to promote safe physical activity. Excessive restriction, especially in young people, may negatively affect mental health, quality of life and overall cardiovascular risk. However, little is known about the physical activity level and physical fitness of patients with LQTS in clinical practice.
This observational study will describe the baseline functional capacity, physical activity level and quality of life of adults with congenital LQTS followed at the Arrhythmia Outpatient Clinic of the Heart Institute (InCor), São Paulo, Brazil, and compare them with patients with arrhythmias and a structurally normal heart. Participants will answer questionnaires on physical activity, quality of life and barriers to exercise, and will undergo cardiopulmonary exercise testing and 24-hour Holter monitoring. This is the first step of the Channelopathies Movement and Exercise Study (CANMOVE).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 years or older
Confirmed diagnosis of congenital long QT syndrome, followed at the Arrhythmia Outpatient Clinic of the Heart Institute (InCor)
Signed informed consent
Disqualifiers
Acquired long QT syndrome
No diagnostic confirmation by clinical and/or genetic criteria, without the possibility of genetic testing as part of routine care
Corrected QT interval (QTc) persistently above 500 ms
Any implantable cardioverter-defibrillator (ICD) therapy or unexplained syncope in the previous 6 months
Trial population
Adults with congenital long QT syndrome followed at the Arrhythmia Outpatient Clinic of the Heart Institute (InCor), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Brazil. Controls are patients with cardiac arrhythmias and a structurally normal heart from the same institution.
Trial design
Case-control
Other
Treatments tested in this trial
Questionnaires
Other interventionInternational Physical Activity Questionnaire short form (IPAQ), 12-Item Short Form Health Survey (SF-12) and structured questionnaire on daily life and barriers to physical activity.
Cardiopulmonary exercise testing
Diagnostic testTreadmill ramp protocol with continuous metabolic, ventilatory and 12-lead electrocardiogram monitoring until exhaustion.
24-hour Holter monitoring
Diagnostic testContinuous 3-channel electrocardiogram recording for 24 hours.
Treatment groups
Trial outcomes
Primary outcomes
Peak oxygen consumption (VO2 peak)
Baseline functional capacity measured as peak oxygen consumption (mL/kg/min) on cardiopulmonary exercise testing.
Secondary outcomes
Physical activity level
Weekly time spent walking and in moderate and vigorous physical activity, measured by the International Physical Activity Questionnaire short form (IPAQ).
Quality of life Questionnaire
Physical and mental component scores of the 12-Item Short Form Health Survey (SF-12). Scores range from 0 to 100, with higher scores indicating better health-related quality of life.
Proportion of patients who wish to engage in physical exercise
Proportion of participants answering yes to the question on willingness to practice physical exercise in the structured daily life questionnaire.
Reasons for not practicing physical exercise
Frequency of each reported reason for not exercising (medical advice, dislike, lack of time, arrhythmia diagnosis, defibrillator shock, device implantation) in the structured daily life questionnaire.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: